Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Blood

• Publication date

  2004-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2003-07-2268PMID 14670926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune thrombocytopenic purpura

  2003cited by this paper
• The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease

  2003cited by this paper
• Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura1

  2002cited by this paper
• Reduced transforming growth factor‐β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura

  2002cited by this paper
• Immune pathophysiology of autoimmune thrombocytopenic purpura.

  2002cited by this paper
• Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis.

  2002cited by this paper
• Immune thrombocytopenic purpura.

  2002cited by this paper
• Functional properties of lymphocytes in idiopathic thrombocytopenic purpura.

  2001cited by this paper
• Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura.

  2001cited by this paper
• The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura.

  2000cited by this paper
• A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura.

  2000cited by this paper
• Comparison of platelet immunity in patients with SLE and with ITP.

  2000cited by this paper
• The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.

  2000cited by this paper
• A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura

  2000cited by this paper
• Plasma‐soluble Fas (APO‐1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura

  2000cited by this paper
• Gender‐related Analysis of Thrombopoietic Cytokine Pattern in Patients with Immune Thrombocytopenic Purpura

  1999cited by this paper
• The cellular immunology associated with autoimmune thrombocytopenic purpura: an update.

  1998cited by this paper
• Role of complement in immune or idiopathic thrombocytopenic purpura

  1998cited by this paper
• Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.

  1998cited by this paper
• Cytokines in idiopathic thrombocytopenic purpura (ITP)

  1998cited by this paper
• Cytokine Flow Cytometry: Understanding Cytokine Biology at the Single-Cell Level

  1997cited by this paper
• Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity.

  1996cited by this paper
• Serum levels of GM‐CSF are elevated in patients with thrombocytopenia

  1996cited by this paper
• Factors affecting the cytokine production of human T cells stimulated by different modes of activation.

  1996cited by this paper
• Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.

  1995cited by this paper
• Cytokines and autoimmune disease.

  1991cited by this paper
• Molecular cloning and structure of the human interleukin-5 gene.

  1987cited by this paper

• [Application of umbilical cord mesenchymal stem cells in the treatment of severe immune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation in children].

  2025cites this paper
• The function of T cells in immune thrombocytopenia

  2025cites this paper
• Cellular immune changes during severe antisense oligonucleotide-associated thrombocytopenia in a nonhuman primate model.

  2025cites this paper
• Evans syndrome revisited.

  2025cites this paper
• Itaconate derivative 4-OI inhibits M1 macrophage polarization and restores its impaired function in immune thrombocytopenia through metabolic reprogramming

  2025cites this paper
• Association of TCRαβ+ double-negative T cells with the response to glucocorticoids in pediatric patients with immune thrombocytopenia

  2025cites this paper
• Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): Lessons from clinical trials.

  2024cites this paper
• Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP).

  2024cites this paper
• Immune thrombocytopenia (ITP) - could it be part of autoimmune/inflammatory syndrome induced by adjuvants (ASIA)?

  2024cites this paper
• Expression of BAFF and IL-10 in Inflammation and Immune-Related Diseases

  2024cites this paper
• Idiopathic Thrombocytopenic Purpura: Current Limitations and Management

  2023cites this paper
• Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP

  2023cites this paper
• Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia.

  2023cites this paper
• Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia.

  2023cites this paper
• TCR CDR3 Sequencing as a Clue to Elucidate the Landscape of Dysimmunity in Patients with Primary Immune Thrombocytopenia

  2022cites this paper
• Empagliflozin modulates CD4+ T‐cell differentiation via metabolic reprogramming in immune thrombocytopenia

  2022influential citation
• Immune Thrombocytopenia in Children: What is the Role of Interleukin-4 and Tumor Necrosis Factor-Alpha?

  2022cites this paper
• Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms

  2022cites this paper
• Recent advances in the mechanisms and treatment of immune thrombocytopenia

  2022cites this paper
• Association of metformin treatment and outcome in adult patients with ITP and pre‐existing T2DM

  2022cites this paper
• Role of IL‐10 and IL‐22 cytokines in patients with primary immune thrombocytopenia and their clinical significance

  2022cites this paper
• ADAP restraint of STAT1 signaling regulates macrophage phagocytosis in immune thrombocytopenia

  2022cites this paper
• Association between the interferon‐γ +874 T/A polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis: A meta‐analysis

  2022influential citation
• Interleukin-37, vascular endothelial growth factor A, and transforming growth factor-β1: promising biomarkers in primary immune thrombocytopenia

  2022cites this paper
• Plasma Level of Interleukin 37 in Children with Primary Immune Thrombocytopenia

  2022cites this paper
• The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients.

  2022cites this paper
• The Construction of ITP Diagnostic Modeling Based on the Expressions of Hub Genes Associated with M1 Polarization of Macrophages

  2022cites this paper
• Dysregulated expression of miRNAs in immune thrombocytopenia.

  2021cites this paper
• Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia

  2021cites this paper
• Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia

  2021cites this paper
• Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia

  2021cites this paper
• Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation

  2021cites this paper
• The Role of Leptin in Childhood Immune Thrombocytopenia (ITP): An Anti-Inflammatory Agent?

  2021cites this paper
• Differential effects of Huaier aqueous extract on human CD4+T lymphocytes from patients with primary immune thrombocytopenia.

  2021cites this paper
• Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia

  2021cites this paper
• CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia.

  2020cites this paper
• Increased levels of IL-10 and IL-1Ra counterbalance the proinflammatory cytokine pattern in acute pediatric immune thrombocytopenia.

  2020cites this paper
• Immune Thrombocytopenia: A Complex Autoimmune Disease

  2020cites this paper
• Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?

  2020cites this paper
• Revisiting the management of chronic ITP; a randomized controlled clinical trial

  2020cites this paper
• IMMUNOMODULATORY EFFECTS OF TGF-β IN THE PATIENTS WITH IMMUNE THROMBOCYTOPENIA

  2020cites this paper
• [Association of Semaphorin 3A with thrombocytopenia in systemic lupus erythematosus].

  2020cites this paper
• Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone

  2020cites this paper
• Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia

  2020cites this paper
• Tacrolimus ameliorates thrombocytopenia in an ITP mouse model

  2020cites this paper
• Emerging role of stem cell memory‐like T cell in immune thrombocytopenia

  2019cites this paper
• Immune thrombocytopenia (ITP): Pathophysiology update and diagnostic dilemmas.

  2019cites this paper
• Relationship between the IL-10 (-1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: A meta-analysis.

  2019cites this paper
• PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients

  2019cites this paper
• A CARD9 single-nucleotide polymorphism rs4077515 is associated with reduced susceptibility to and severity of primary immune thrombocytopenia

  2019cites this paper
• High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia

  2019cites this paper
• Plasma levels and expression of interleukin-37 in patients with immune thrombocytopenia.

  2019cites this paper
• Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.

  2019cites this paper
• IP-10 and MCP-1 gene polymorphisms in Chinese patients with chronic immune thrombocytopenia

  2019cites this paper
• Idiopathic thrombocytopenic purpura (ITP) – new era for an old disease

  2019cites this paper
• Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

  2019influential citation
• Involvement of Interferon-γ + 874A/T Polymorphism in the Pathogenesis of and Therapeutic Response to Immune Thrombocytopenia.

  2019cites this paper
• Updates in Immune Thrombocytopenia: Terminology, Immunomodulation and Platelet Stimulation, and Clinical Guidelines and Management

  2018cites this paper
• Increased expression of interleukin-17 is associated with macrophages in chronic immune thrombocytopenia.

  2018cites this paper
• Importance of Th22 Cell Disequilibrium in Immune Thrombocytopenic Purpura

  2018cites this paper
• ÉTUDE DES CELLULES LYMPHOÏDES INNÉES SPLÉNIQUES HUMAINES ET DE LEURS IMPLICATIONS AU COURS DE LA THROMBOPÉNIE IMMUNOLOGIQUE

  2018influential citation
• Platelets in Immune Response to Virus and Immunopathology of Viral Infections

  2018cites this paper
• Management of immune thrombocytopenia in elderly patients.

  2018cites this paper
• IMMUNE THROMBOCYTOPENIA. EGYPTIAN EXPERIENCE WITH STUDY OF IL-17, TGFB, CYTOKINES IN CHRONIC AND PERSISTENT IMMUNE THROMBOCYTOPENIA PATIENTS.

  2018cites this paper
• T helper 1/T helper 2-associated chemokine and chemokine receptor expression in immune thrombocytopenia

  2018cites this paper
• Association of IL-17A and IL-17F Gene Polymorphisms with Acute Immune Thrombocytopenia in Egyptian Children

  2018cites this paper
• Chronic immune thrombocytopenia. Egyptian experience

  2018cites this paper
• High‐dose dexamethasone or all‐trans‐retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia

  2017cites this paper
• The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP

  2017influential citation
• Patterns of Care and Association of Response with Rituximab among Patients of Immune Thrombocytopenia Purpura in a Rural Practice

  2017influential citation
• Decreased Frequency of IL-17F rs763780 Site Allele G is Associated With Genetic Susceptibility to Immune Thrombocytopenia in a Chinese Population

  2017cites this paper
• Icaritin Improves Antibody-Induced Thrombocytopenia in a Mouse Model by Regulating T-cell Polarization

  2017influential citation
• Mouse immune thrombocytopenia is associated with Th1 bias and expression of activating Fcγ receptors

  2017cites this paper
• Role of measurement of interleukin 10 in idiopathic (immune) thrombocytopenic purpura

  2017cites this paper
• Abnormal Distribution and Function of Monocyte Subsets in Patients With Primary Immune Thrombocytopenia

  2017cites this paper
• Pathogenesis of immune thrombocytopenia.

  2017cites this paper
• Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia

  2017cites this paper
• Increased plasma sCXCL16 levels may have a relationship with Th1/Th2 imbalance in primary immune thrombocytopenia

  2017cites this paper
• Submucosal esophageal hematoma precipitated by chronic idiopathic thrombocytopenic purpura

  2017cites this paper
• Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia

  2017cites this paper
• The role of splenectomy in autoimmune hematological disorders: Outdated or still worth considering?

  2017cites this paper
• Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP)

  2017cites this paper
• Granulocyte colony-stimulating factor decreases the Th1/Th2 ratio in peripheral blood mononuclear cells from patients with chronic immune thrombocytopenic purpura in vitro.

  2016cites this paper
• Role of interleukin-27 in immune thrombocytopenic purpura and its impact on disease response

  2016cites this paper
• Participation of B‐cell‐activating factor receptors in the pathogenesis of immune thrombocytopenia

  2016cites this paper
• Influence of Intravenous Immunoglobulin and Methylprednisolone on Cytokines secreted by T Lymphocyte in Children Primary Immune Thrombocytopenia 1

  2016cites this paper
• Atopic dermatitis and association of risk for primary immune thrombocytopenia and autoimmune diseases among children

  2016cites this paper
• Advances in Diagnosis and Treatments for Immune Thrombocytopenia

  2016cites this paper
• Targeting autophagy as a potential therapeutic approach for immune thrombocytopenia therapy.

  2016cites this paper
• Association between interferon-γ +874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis

  2016cites this paper
• Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

  2016cites this paper
• Interleukin-17A and -17F Gene Polymorphisms in Chinese Population with Chronic Immune Thrombocytopenia.

  2016cites this paper
• Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia

  2016cites this paper
• Identification of novel biomarkers in chronic immune thrombocytopenia (ITP) by microarray‐based serum protein profiling

  2016cites this paper
• RhIL-11 treatment normalized Th1/Th2 and T-bet/GATA-3 imbalance in in human immune thrombocytopenic purpura (ITP).

  2016cites this paper
• Management of paediatric immune thrombocytopaenia in a South African centre from 1991-2011

  2016cites this paper
• T cells in the pathogenesis of immune thrombocytopenia.

  2016cites this paper
• The Centenary of Immune Thrombocytopenia – Part 1: Revising Nomenclature and Pathogenesis

  2016cites this paper
• Elevated expression of IL-12 and IL-23 in patients with primary immune thrombocytopenia

  2015cites this paper
• Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation

  2015cites this paper